Sat Kartar Life Ltd Q2 FY2027 Concall Summary

Source transcript PDF: https://assets.stockscans.in/docs/xji542xv4s79i3599j31mkb1.pdf

Key Takeaways


The Hospital Acceleration

Manprit Singh Chadha: “I don't want to radically change the industry, but when we say that revenue per bed, I really fail to understand that why are we always talking in a hospital about a bed revenue? ... We did it with all the day therapies, the day OPD. So, revenue per bed, if I talk about the industry benchmark, it's claimed INR10,000. I would say why INR10,000?”

Revenue Guidance Reset

Manprit Singh Chadha: “Yes, I am lowering, if you take it that way, I am lowering my guidance with a rider that hospitals were brought in because we thought that margins should improve as such for a company. When I'm lowering my guidance, I'm improving the margins.”

Product Business & Core Growth


US & International Expansion


Partnerships & Operational Updates


Bed Rollout & Capacity Build

Manprit Singh Chadha: “Yes, we are still on track for that, and we are more than confident on that than earlier because with this hospital business starting and, in fact, the first hospital being breakeven and next five hospitals coming in this quarter itself, that INR500 crores in FY28 is still very much intact with a far better profitability than what was earlier discussed.”

Guidance & Commitments

CommitmentSpecificsTimeline
Revenue growth30–35% YoY, with 5–10% downside to earlier ₹300 cr targetFY27 full year
PAT margin11–12%, with ~1% headwind possible from hospital depreciationFY27 full year
FY28 revenue₹500 crores, with ₹150–200 cr from hospitalsFY28
FY28 PAT margin17–18% (raised from earlier 14–15%)FY28
Hospital openingsFive more hospitals in Q3 FY27; Gurgaon around DiwaliQ3 FY27
Hospital beds300 beds (all Sat Kartar); 200 achievable soon, 100 more by next quarter startFY27
Hospital beds1,000 beds, including Jeena Sikho collaboration in South IndiaFY28
New hospital breakeven60–90 days from openingPer-unit target
Hospital unit PAT25–30% within a year of breakevenPer-unit target
US revenue startRevenue flow from November onwardsNovember 2026
Jeena Sikho revenueContribution could begin in later part of Q3 FY27Q3 FY27
South India hospitalsStart in last quarter of FY27; Jeena Sikho framework framed thenQ4 FY27
GST refundsMonth-on-month liquidity from 1st NovemberEffective 1 Nov 2026

Key Metrics

MetricH1 FY27
Consolidated revenue from operations₹113.9 cr, +26.4% YoY
EBITDA₹14.5 cr, +47.7% YoY
EBITDA margin12.7%, improved 180 bps YoY
Profit after tax₹9.25 cr, +26.7% YoY
PAT margin~8%
Revenue growth outlook30% to 35% YoY, subject to business conditions
FY27 revenue guidance₹300 cr with a downside of around 5% to 10%
FY28 revenue guidance₹500 cr, intact with better profitability than earlier discussed
FY28 revenue bifurcation₹150 cr to ₹200 cr from hospitals, rest from product business
FY27 PAT margin target11% to 12%
FY28 PAT margin target17% to 18%, revised from 14% to 15%
Hospital monthly revenue (September 2026)₹22 lakhs, ramped from ₹5–6 lakhs
H1 hospital revenue contribution~₹55 lakhs
FY27 bed target300 beds, on track, all Sat Kartar Life
FY28 bed target1,000 beds, includes Jeena Sikho collaboration in South
Hospital unit size strategy10 to 30 beds per unit
Hospital unit breakeven target60 to 90 days
Hospital unit PAT target after one year25% to 30%
Repeat customer revenue share23.5%
Revenue per advisor per day target₹7,000 to ₹8,000
Total advisor force1,600, 60% employees, 40% freelance
Fertility business share of revenue60%
Marketing spend in product vertical40% of revenue
AI-driven customer interactionsNot more than 1%
H1 PlantoMed revenue₹6 cr to ₹7 cr
GTA GST refundFrom 1st November, previously stuck amounts become liquid cash